[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus].

V. Guadagnino,G. Borgia,A. Chirianni,R. Orlando,L. Picciotto,P. Tullio Cataldo,M. Piazza
1980-02-29
Abstract:Treatment with Cardiostenol (commercial name of a pharmaceutical product containing morphine chloridrate+atropine+sparteine) does not modify the course of hepatitis in mice infected with MHV-3 virus. Similar results were previously obtained by treatment with morphine chloridrate alone.
What problem does this paper attempt to address?